Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2017-02080PMID 29220529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin treatment in children with Prader–Willi syndrome: A double‐blind, placebo‐controlled, crossover study

  2017cited by this paper
• Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats.

  2017cited by this paper
• Oxytocin under opioid antagonism leads to supralinear enhancement of social attention

  2017cited by this paper
• Oxytocin administration suppresses hypothalamic activation in response to visual food cues

  2017cited by this paper
• Effects of Opioid Antagonism on Cerebrospinal Fluid Melanocortin Peptides and Cortisol Levels in Humans

  2017cited by this paper
• Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men

  2016cited by this paper
• Oxytocin in survivors of childhood-onset craniopharyngioma

  2016cited by this paper
• Intranasal Oxytocin: Myths and Delusions.

  2016cited by this paper
• Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior

  2016cited by this paper
• Chronic Oxytocin Administration as a Treatment Against Impaired Leptin Signaling or Leptin Resistance in Obesity

  2015cited by this paper
• Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans.

  2015cited by this paper
• Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity

  2015cited by this paper
• Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity

  2015cited by this paper
• Oxytocin reduces caloric intake in men

  2015cited by this paper
• Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity.

  2015cited by this paper
• Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys.

  2015cited by this paper
• Diagnosis and Treatment of Hypopituitarism

  2015cited by this paper
• Craniopharyngioma.

  2014cited by this paper
• CSF and Blood Oxytocin Concentration Changes following Intranasal Delivery in Macaque

  2014cited by this paper
• Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure.

  2014cited by this paper
• Leptin Activates Oxytocin Neurons of the Hypothalamic Paraventricular Nucleus in Both Control and Diet-Induced Obese Rodents

  2013cited by this paper
• Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models

  2013cited by this paper
• Oxytocin Reduces Reward-Driven Food Intake in Humans

  2013cited by this paper
• Obesity and addiction: neurobiological overlaps

  2013cited by this paper
• Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans

  2013cited by this paper
• Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like Eating

  2012cited by this paper
• Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.

  2012cited by this paper
• Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment.

  2011cited by this paper
• Social effects of oxytocin in humans: context and person matter.

  2011cited by this paper
• Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass

  2011cited by this paper
• Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese Rats

  2011cited by this paper
• Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans

  2011cited by this paper
• Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus

  2010cited by this paper
• The effects of opioids and opioid analogs on animal and human endocrine systems.

  2010cited by this paper
• Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium

  2009cited by this paper
• Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma

  2005cited by this paper
• [Diagnosis and treatment of hypopituitarism].

  2005cited by this paper
• G PROTEIN-COUPLED RECEPTOR SIGNALLING IN NEUROENDOCRINE SYSTEMS Molecular regulation of the oxytocin receptor in peripheral organs

  2003cited by this paper
• Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis

  2002cited by this paper
• Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship

  2002cited by this paper
• The oxytocin receptor system: structure, function, and regulation.

  2001cited by this paper
• Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect.

  1997cited by this paper
• Selective effects of naltrexone on food pleasantness and intake.

  1996cited by this paper
• Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study.

  1991cited by this paper
• Prader-Willi syndrome

  1989cited by this paper
• Effect of naltrexone on food intake, hunger, and satiety in obese men.

  1987cited by this paper
• Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis

  1982cited by this paper

• Current and Future Pharmacological Interventions for Acquired Hypothalamic Obesity.

  2026cites this paper
• A comprehensive analysis of oxytocin: a potential brain-based treatment to regulate obesity

  2026influential citation
• Impact of eating behaviour on craniopharyngioma-associated obesity

  2026cites this paper
• Appetite sensations and hormonal secretion in patients with adamantinomatous craniopharyngioma.

  2025cites this paper
• Oxytocin: a neglected hormone in pituitary disease - From function to the diagnosis of a deficiency, resulting clinical relevance, and potential treatment options in endocrinology

  2025cites this paper
• Diagnostic criteria for acquired hypothalamic obesity – international expert guidance document

  2025cites this paper
• Long-term intranasal oxytocin therapy in patients with hypothalamic syndrome: case series and literature review

  2025cites this paper
• Oxytocin in hypopituitarism: What do we know?

  2025cites this paper
• Oxytocin and opioid antagonists: A dual approach to improving social behavior

  2025cites this paper
• Diagnostik und Therapie der hypothalamischen Adipositas

  2025cites this paper
• Management of Acquired Hypothalamic Obesity After Childhood-Onset Craniopharyngioma—A Narrative Review

  2025cites this paper
• Metabolic complications and their mechanisms in patients with craniopharyngioma.

  2025cites this paper
• Long-term quality of life and hypothalamic dysfunction after craniopharyngioma

  2025cites this paper
• The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease

  2025cites this paper
• Editorial: Oxytocin and metabolic dysregulation: from pathophysiology to pharmacotherapy

  2025cites this paper
• Arginine Vasopressin (AVP) Deficiency: Diagnosis and Treatment – An Update

  2025cites this paper
• Arginine Vasopressin Deficiency and Oxytocin Deficiency in the Endocrine Clinic.

  2025cites this paper
• µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice

  2024cites this paper
• Treatment of Hypothalamic Obesity With GLP-1 Analogs

  2024cites this paper
• Effectiveness of bariatric surgery on acquired hypothalamic obesity: a systematic review and meta-analysis

  2024cites this paper
• The oxytocin system in patients with craniopharyngioma: A systematic review

  2024influential citation
• Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions

  2024cites this paper
• The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management

  2024cites this paper
• Acquired hypothalamic obesity: A clinical overview and update

  2024cites this paper
• Approccio all’obesità ipotalamica: presente e futuro

  2024cites this paper
• The Long Way of Oxytocin from the Uterus to the Heart in 70 Years from Its Discovery

  2023cites this paper
• Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity

  2023cites this paper
• The neurohypophyseal hormone oxytocin and eating behaviors: a narrative review

  2023cites this paper
• The use of intranasal oxytocin in the treatment of eating disorders.

  2023cites this paper
• Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon

  2023cites this paper
• Intranasal oxytocin as a treatment for obesity: safety and efficacy

  2023cites this paper
• A Pilot Randomized Clinical Trial of Intranasal Oxytocin to Promote Weight Loss in Individuals With Hypothalamic Obesity

  2023influential citation
• Evaluating Eating Behaviour, Energy Homeostasis, and Obesity in Childhood-Onset Craniopharyngioma: A Feasibility Study

  2023cites this paper
• Hypothalamic syndrome

  2022cites this paper
• Oxytocin as a potential pharmacological tool to combat obesity

  2022cites this paper
• Chronic Intermittent Sucrose Consumption Facilitates the Ability to Discriminate Opioid Receptor Blockade with Naltrexone in Rats

  2022cites this paper
• Treatment of Acquired Hypothalamic Obesity: Now and the Future

  2022cites this paper
• Oxytocin Therapy May Improve Eating Behaviors in Children with Single-Minded-1 Gene Mutation

  2022cites this paper
• Quality of Life in Craniopharyngioma: A Systematic Review.

  2022cites this paper
• Long-term outcomes in patients with adult-onset craniopharyngioma

  2022cites this paper
• Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight

  2022cites this paper
• Inhibition of integrated stress response protects against lipid-induced senescence in hypothalamic neural stem cells in adamantinomatous craniopharyngioma.

  2022cites this paper
• Contemporary Biological Insights and Clinical Management of Craniopharyngioma.

  2022cites this paper
• Acute Hypophagia and Changes in c-Fos Immunoreactivity in Adolescent Rats Treated with Low Doses of Oxytocin and Naltrexone

  2021cites this paper
• Hindbrain Administration of Oxytocin Reduces Food Intake, Weight Gain and Activates Catecholamine Neurons in the Hindbrain Nucleus of the Solitary Tract in Rats

  2021cites this paper
• Obesità post-neurochirurgia ipotalamica

  2021cites this paper
• Oxytocin as an Anti-obesity Treatment

  2021influential citation
• Craniopharyngiomas.

  2021cites this paper
• Effects of Combined Oxytocin and Beta-3 Receptor Agonist (CL 316243) Treatment on Body Weight and Adiposity in Male Diet-Induced Obese Rats

  2021cites this paper
• The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans

  2021cites this paper
• Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats

  2021cites this paper
• Oxytocin, eating behavior, and metabolism in humans.

  2021cites this paper
• Multidisciplinary Approach for Hypothalamic Obesity in Children and Adolescents: A Preliminary Study

  2021cites this paper
• Childhood-onset Craniopharyngioma

  2021cites this paper
• Effect of combination of peripheral oxytocin and naltrexone at subthreshold doses on food intake, body weight and feeding-related brain gene expression in male rats.

  2021cites this paper
• Childhood-onset craniopharyngiomas

  2021cites this paper
• Postoperative and Long-Term Endocrinologic Complications of Craniopharyngioma

  2021cites this paper
• Disease and Treatment-Related Hypothalamic Alterations in Craniopharyngioma: Clinical Presentation, Prognostic Impact, and Implications for Treatment Strategies

  2020cites this paper
• Hypothalamic Disorders During Ovulation, Pregnancy, and Lactation

  2020cites this paper
• The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis

  2020cites this paper
• Insights into non-classic and emerging causes of hypopituitarism

  2020cites this paper
• Creative and Innovative Methods and Techniques for the Challenges in the Management of Adult Craniopharyngioma.

  2020cites this paper
• SIOP PODC–adapted treatment guidelines for craniopharyngioma in low‐ and middle‐income settings

  2020cites this paper
• Management of Hypothalamic Obesity.

  2020cites this paper
• Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity

  2020cites this paper
• Adult Craniopharyngiomas: Differences and Lessons from Paediatrics

  2020cites this paper
• Adamantinomatous Craniopharyngioma: Genomics, Radiologic Findings, Clinical, and Prognosis

  2019cites this paper
• Pharmacotherapy of obesity: Available medications and drugs under investigation.

  2019cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Childhood-onset Craniopharyngioma: state of the art of care in 2018.

  2019cites this paper
• Craniopharyngioma

  2019cites this paper
• Metabolic Effects of Oxytocin.

  2019cites this paper
• The Diagnosis and Treatment of Craniopharyngioma

  2019cites this paper
• Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice

  2019cites this paper
• Eating behaviour and oxytocin in patients with childhood‐onset craniopharyngioma and different grades of hypothalamic involvement

  2019cites this paper
• Hypothalamic Obesity: Prologue and Promise

  2019cites this paper
• Childhood-onset craniopharyngioma: state of the art of care in 2018

  2019cites this paper
• Oxytocin alterations and neurocognitive domains in patients with hypopituitarism

  2019cites this paper
• Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.

  2018cites this paper
• Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up

  2018cites this paper
• Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females

  2018cites this paper
• Oxytocin therapy in hypopituitarism: Challenges and opportunities

  2018cites this paper
• Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.

  2018cites this paper
• Hypothalamic Obesity Treatment Demands Thinking Outside the Box

  2018cites this paper
• Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

  2018cites this paper